REFERENCES
1. Hu C. Grants supporting research in China. Eur Heart J . 2018;39:2342-2344.
2. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med . 2022;28:583-590.
3. Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med . 1985;3131:1330-1340.
4. Bayes-Genis A, Conover CA, Schwartz RS. The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ Res . 2000;86:125-130.
5. Bush EW, McKinsey TA. Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors. Circ Res . 2010;106:272-284.
6. Yan SF, Ramasamy R, Schmidt AM. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res . 2010;106:842-853. l
7.El Refaey M, Musa H, Murphy NP, et al. Protein Phosphatase 2A Regulates Cardiac Na+ Channels. Circ Res . 2019;124:737-746.
8.Emami H, Singh P, MacNabb M, et al. Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans. JACC Cardiovasc Imaging . 2015;8:121-130.
9.Ismahil MA, Hamid T, Bansal SS, Patel B, Kingery JR, Prabhu SD. Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis. Circ Res . 2014;114:266-282.
10.Wang L, Zhang YL, Lin QY, et al. CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration. Eur Heart J . 2018;39:1818-1831.
11.Döring Y, Noels H, van der Vorst EPC, et al. Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity: Evidence From Mouse and Human Studies. Circulation . 2017;136:388-403.
12.Seeger FH, Rasper T, Fischer A, et al. Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair.Circ Res . 2012;111:854-862.
13.Zhuang R, Chen J, Cheng HS, et al. Perivascular Fibrosis Is Mediated by a KLF10-IL-9 Signaling Axis in CD4+ T Cells. Circ Res . 2022;130:1662-1681.
14.Abohashem S, Osborne MT, Dar T, et al. A leucopoietic-arterial axis underlying the link between ambient air pollution and cardiovascular disease in humans. Eur Heart J . 2021;42:761-772.
15.Hung MY, Witztum JL, Tsimikas S. New therapeutic targets for calcific aortic valve stenosis: the lipoprotein(a)-lipoprotein-associated phospholipase A2-oxidized phospholipid axis. J Am Coll Cardiol . 2014;63:478-480.
16.Paulin R, Sutendra G, Gurtu V, et al. A miR-208-Mef2 axis drives the decompensation of right ventricular function in pulmonary hypertension.Circ Res . 2015;116:56-69.
17.Zhang Y, Wang Y, Zhang L, et al. Reduced Platelet miR-223 Induction in Kawasaki Disease Leads to Severe Coronary Artery Pathology Through a miR-223/PDGFRβ Vascular Smooth Muscle Cell Axis. Circ Res . 2020;127:855-873.
18.Liu X, Guo JW, Lin XC, et al. Macrophage NFATc3 prevents foam cell formation and atherosclerosis: evidence and mechanisms. Eur Heart J . 2021;42:4847-4861.
19.Ljubojevic-Holzer S, Herren AW, Djalinac N, et al. CaMKIIδC Drives Early Adaptive Ca2+ Change and Late Eccentric Cardiac Hypertrophy. Circ Res . 2020;127:1159-1178.
20.Cui H, Chen Y, Li K, et al. Untargeted metabolomics identifies succinate as a biomarker and therapeutic target in aortic aneurysm and dissection. Eur Heart J . 2021;42:4373-4385.
21. Xiao N, Liu TL, Li H, et al. Low Serum Uric Acid Levels Promote Hypertensive Intracerebral Hemorrhage by Disrupting the Smooth Muscle Cell-Elastin Contractile Unit and Upregulating the Erk1/2-MMP Axis.Transl Stroke Res . 2020;11:1077-1094.
22. Li Q, Huang K, Ma T, et al. Metoprolol Protects Against Arginine Vasopressin-Induced Cellular Senescence in H9C2 Cardiomyocytes by Regulating the Sirt1/p53/p21 Axis. Cardiovasc Toxico . 2022;22:99-107.
23.Zhang H, Xu A, Sun X, et al. Self-Maintenance of Cardiac Resident Reparative Macrophages Attenuates Doxorubicin-Induced Cardiomyopathy Through the SR-A1-c-Myc Axis. Circ Res . 2020;127:610-627.
24.El-Sammak H, Yang B, Guenther S, Chen W, Marín-Juez R, Stainier DYR. A Vegfc-Emilin2a-Cxcl8a Signaling Axis Required for Zebrafish Cardiac Regeneration. Circ Res . 2022;130:1014-1029
25.Zheng Y, Huang S, Zhang J, et al. Melatonin alleviates vascular endothelial cell damage by regulating an autophagy-apoptosis axis in Kawasaki disease. Cell Prolif . 2022;55:e13251.
26. Ma QX, Zhu WY, Lu XC, et al. BCAA-BCKA axis regulates WAT browning through acetylation of PRDM16. Nat Metab . 2022;4:106-122.
27. Lin DS, Zhang CY, Li L, Ye GH, Jiang LP, Jin Q. Circ_ROBO2/miR-149 Axis Promotes the Proliferation and Migration of Human Aortic Smooth Muscle Cells by Activating NF-κB Signaling. Cytogenet Genome Res . 2021;161:414-424.
28. Perry RJ, Peng L, Barry NA, et al. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome.Nature . 2016;534:213-217.
29. Weng G, Gu M, Zhang Y, Zhao G, Gu Y. LINC01123 promotes cell proliferation and migration via regulating miR-1277-5p/KLF5 axis in ox-LDL-induced vascular smooth muscle cells. J Mol Histol . 2021;52:943-953.
30. Peng W, Li T, Pi S, Huang L, Liu Y. Suppression of circular RNA circDHCR24 alleviates aortic smooth muscle cell proliferation and migration by targeting miR-149-5p/MMP9 axis. Biochem Biophys Res Commun . 2020;529:753-759.
31. Gu J, Shi JZ, Wang YX, et al. LncRNA FAF attenuates hypoxia/ischaemia-induced pyroptosis via the miR-185-5p/PAK2 axis in cardiomyocytes. J Cell Mol Med . 2022;26:2895-2907.
32. Ding S, Abudupataer M, Zhou Z, et al. Histamine deficiency aggravates cardiac injury through miR-206/216b-Atg13 axis-mediated autophagic-dependant apoptosis. Cell Death Dis . 2018;9:694.
33. Chen Q, Lin G, Lin L, et al. LncRNA XR_596701 protects H9c2 cells against intermittent hypoxia-induced injury through regulation of the miR-344b-5p/FAIM3 axis. Cell Death Discov . 2022;8:42.
34. Xiong X, Liu J, He Q, et al. Long non-coding RNA NORAD aggravates acute myocardial infarction by promoting fibrosis and apoptosis via miR-577/COBLL1 axis. Environ Toxicol . 2021;36:2256-2265.
35. Huang HS, Huang XY, Yu HZ, Xue Y, Zhu PL. Circular RNA circ-RELL1 regulates inflammatory response by miR-6873-3p/MyD88/NF-κB axis in endothelial cells. Biochem Biophys Res Commun . 2020;525:512-519.
36. Yang GS, Zheng B, Qin Y, et al. Salvia miltiorrhiza-derived miRNAs suppress vascular remodeling through regulating OTUD7B/KLF4/NMHC IIA axis. Theranostics . 2020;10:7787-7811.
37. Liu J, Wang C, Li J, et al. Autophagy blockage promotes the pyroptosis of ox-LDL-treated macrophages by modulating the p62/Nrf2/ARE axis. J Physiol Biochem . 2021;77:419-429.
38. Shiroorkar PN, Afzal O, Kazmi I, et al. Cardioprotective Effect of Tangeretin by Inhibiting PTEN/AKT/mTOR Axis in Experimental Sepsis-Induced Myocardial Dysfunction. Molecules . 2020;25:5622.
39. Nie T, Hui X, Mao L, et al. Harmine Induces Adipocyte Thermogenesis through RAC1-MEK-ERK-CHD4 Axis. Sci Rep . 2016;6:36382.
40. Ling S, Ni RZ, Yuan Y, et al. Natural compound bavachalcone promotes the differentiation of endothelial progenitor cells and neovascularization through the RORα-erythropoietin-AMPK axis.Oncotarget . 2017;8:86188-86205.
41. Wilck N, Matus MG, Kearney SM, et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nature . 2017;551:585-589.
42. Peng F, Zhang N, Wang C, et al. Aconitine induces cardiomyocyte damage by mitigating BNIP3-dependent mitophagy and the TNFα-NLRP3 signalling axis. Cell Prolif . 2020;53:e12701.
43. Santisteban MM, Kim S, Pepine CJ, Raizada MK. Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics. Circ Res . 2016;118:1327-1336.
44. Tahsili-Fahadan P, Geocadin RG. Heart-Brain Axis: Effects of Neurologic Injury on Cardiovascular Function. Circ Res . 2017;120:559-572.
45. Georgakis MK, Bernhagen J, Heitman LH, Weber C, Dichgans M. Targeting the CCL2-CCR2 axis for atheroprotection. Eur Heart J . 2022;43:1799-1808.
46. Crea F. New therapeutic targets to reduce inflammation-associated cardiovascular risk: the CCL2-CCR2 axis, LOX-1, and IRF5. Eur Heart J . 2022;43:1777-1781.
47. Mohanta SK, Peng L, Li Y, et al. Neuroimmune cardiovascular interfaces control atherosclerosis. Nature . 2022;605:152-159.
48. Giussani DA. Breath of Life: Heart Disease Link to Developmental Hypoxia. Circulation . 2021;144:1429-1443.
49. Tang WH, Kitai T, Hazen SL. Gut Microbiota in Cardiovascular Health and Disease. Circ Res . 2017;120:1183-1196.
50. King JB, Pinheiro LC, Bryan Ringel J, et al. Multiple Social Vulnerabilities to Health Disparities and Hypertension and Death in the REGARDS Study. Hypertension . 2022;79:196-206.
51. van Laer SD, Snijder MB, Agyemang C, Peters RJ, van den Born BH. Ethnic differences in hypertension prevalence and contributing determinants - the HELIUS study. Eur J Prev Cardiol . 2018;25:1914-1922.
52. Rietveld CA, Medland SE, Derringer J, et al. GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science . 2013;340:1467-1471.
53. Okbay A, Beauchamp JP, Fontana MA, et al. Genome-wide association study identifies 74 loci associated with educational attainment.Nature . 2016;533:539-542.
54. Okbay A, Wu Y, Wang N, et al. Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals. Nat Genet . 2022;54:437-449.
55. Younan D, Wang X, Millstein J, et al. Air quality improvement and cognitive decline in community-dwelling older women in the United States: A longitudinal cohort study. PLoS Med . 2022;19:e1003893.
56. Hu CS, Tkebuchava T. SEEDi1.0-3.0 strategies for major noncommunicable diseases in China. J Integr Med . 2017;15:265-269.
57. Hu CS, Tkebuchava T. E-noise: An increasingly relevant health risk.J Integr Med . 2019;17:311-314.
58. Chen R, Jiang Y, Hu J, et al. Hourly Air Pollutants and Acute Coronary Syndrome Onset In 1.29 Million Patients. Circulation . 2022;145:1749-1760.
59. Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet . 2020;395:795-808.
60. Jowell AR, Sarma AA, Gulati M, et al. Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes: A Review.JAMA Cardiol . 2022;7:346-355.
61. Benagiano M, Mancuso S, Brosens JJ, Benagiano G. Long-Term Consequences of Placental Vascular Pathology on the Maternal and Offspring Cardiovascular Systems. Biomolecules . 2021;11:1625.
62. Yang H, Wu J, Huang X, et al. ABO genotype alters the gut microbiota by regulating GalNAc levels in pigs. Nature . 2022;606:358-367.
63. Bai PY, Chen SQ, Jia DL, et al. Environmental eustress improves postinfarction cardiac repair via enhancing cardiac macrophage survival.Sci Adv . 2022;8:eabm3436.
64. Coppini R, Santini L, Olivotto I, Ackerman MJ, Cerbai E. Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy. Cardiovasc Res . 2020;116:1585-1599.
65. Crotti L, Odening KE, Sanguinetti MC. Heritable arrhythmias associated with abnormal function of cardiac potassium channels.Cardiovasc Res . 2020;116:1542-1556.
66. Garshick MS, Nikain C, Tawil M, et al. Reshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in mice. Sci Rep . 2021;11:8966.
67. Guo X, Dai X, Zhou T, et al. Mosaic loss of human Y chromosome: what, how and why. Hum Genet . 2020;139:421-446.
68. Cooke CM, Davidge ST. Advanced maternal age and the impact on maternal and offspring cardiovascular health. Am J Physiol Heart Circ Physiol . 2019;317:H387-H394.
69. Taylor AJ, Rogan KM, Virmani R. Sudden cardiac death associated with isolated congenital coronary artery anomalies. J Am Coll Cardiol . 1992;20:640-647.
70. Talmor-Barkan Y, Bar N, Shaul AA, et al. Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease.Nat Med . 2022;28:295-302.
71. Wang N, Sun Y, Zhang H, et al. Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease. Eur Heart J . 2021;42:4180-4188.
72. Zhang SL, Bai L, Goel N, et al. Human and rat gut microbiome composition is maintained following sleep restriction. Proc Natl Acad Sci U S A . 2017;114:E1564-E1571.
73. Grosicki GJ, Riemann BL, Flatt AA, Valentino T, Lustgarten MS. Self-reported sleep quality is associated with gut microbiome composition in young, healthy individuals: a pilot study. Sleep Med . 2020;73:76-81.
74. Maki KA, Burke LA, Calik MW, et al. Sleep fragmentation increases blood pressure and is associated with alterations in the gut microbiome and fecal metabolome in rats. Physiol Genomics . 2020;52:280-292.
75. Liu Z, Wei ZY, Chen J, et al. Acute Sleep-Wake Cycle Shift Results in Community Alteration of Human Gut Microbiome. mSphere . 2020;5:e00914-e00919.
76. Jiang Z, Zhuo LB, He Y, et al.The gut microbiota-bile acid axis links the positive association between chronic insomnia and cardiometabolic diseases. Nat Commun . 2022;13:3002.
77. Durgan DJ, Ganesh BP, Cope JL, et al. Role of the Gut Microbiome in Obstructive Sleep Apnea-Induced Hypertension. Hypertension . 2016;67:469-474.
78. Levine GN, Cohen BE, Commodore-Mensah Y, et al. Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association. Circulation . 2021;143:e763-e783.
79. Levine GN, Lange RA, Bairey-Merz CN, et al. American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Hypertension. Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association. J Am Heart Assoc . 2017;6:e002218.
80. Ponte Márquez PH, Feliu-Soler A, Solé-Villa MJ, et al. Benefits of mindfulness meditation in reducing blood pressure and stress in patients with arterial hypertension. J Hum Hypertens . 2019;33:237-247.
81. Krittanawong C, Kumar A, Wang Z, et al. Meditation and Cardiovascular Health in the US. Am J Cardiol . 2020;131:23-26.
82. Aggarwal M, Bozkurt B, Panjrath G, et al. American College of Cardiology’s Nutrition and Lifestyle Committee of the Prevention of Cardiovascular Disease Council. Lifestyle Modifications for Preventing and Treating Heart Failure. J Am Coll Cardiol . 2018;72:2391-2405.
83. Jia W, Zhen J, Liu A, et al. Long-Term Vegan Meditation Improved Human Gut Microbiota. Evid Based Complement Alternat Med . 2020;2020:9517897.
84. Leonardi I, Gao IH, Lin WY, et al. Mucosal fungi promote gut barrier function and social behavior via Type 17 immunity. Cell . 2022;185:831-846.e14.
85. Mayneris-Perxachs J, Castells-Nobau A, Arnoriaga-Rodríguez M, et al. Microbiota alterations in proline metabolism impact depression.Cell Metab . 2022;34:681-701.e10.
86. Carloni S, Bertocchi A, Mancinelli S, et al. Identification of a choroid plexus vascular barrier closing during intestinal inflammation.Science . 2021;374:439-448.
87. Barki N, Bolognini D, Börjesson U, et al. Chemogenetics defines a short-chain fatty acid receptor gut-brain axis. Elife . 2022;11:e73777.
88. Klopack ET, Crimmins EM, Cole SW, Seeman TE, Carroll JE. Social stressors associated with age-related T lymphocyte percentages in older US adults: Evidence from the US Health and Retirement Study. Proc Natl Acad Sci U S A . 2022;119:e2202780119.
89. Cooper DM, Radom-Aizik S. Exercise-associated prevention of adult cardiovascular disease in children and adolescents: monocytes, molecular mechanisms, and a call for discovery. Pediatr Res . 2020;87:309-318.
90. Xia WJ, Xu ML, Yu XJ, et al. Antihypertensive effects of exercise involve reshaping of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rat. Gut Microbes . 2021;13:1-24.
91. Li Y, Zafar S, Salih Ibrahim RM, et al. Exercise and food supplement of vitamin C ameliorate hypertension through improvement of gut microflora in the spontaneously hypertensive rats. Life Sci . 2021;269:119097.
92. Liu Z, Liu HY, Zhou H, et al. Moderate-Intensity Exercise Affects Gut Microbiome Composition and Influences Cardiac Function in Myocardial Infarction Mice. Front Microbiol . 2017;8:1687.
93. Zhou Q, Deng J, Pan X, et al. Gut microbiome mediates the protective effects of exercise after myocardial infarction. Microbiome . 2022;10:82.
94. Taniguchi H, Tanisawa K, Sun X, et al. Effects of short-term endurance exercise on gut microbiota in elderly men. Physiol Rep . 2018;6:e13935.
95. Huang WC, Tung CL, Yang YSH, Lin IH, Ng XE, Tung YT. Endurance exercise ameliorates Western diet-induced atherosclerosis through modulation of microbiota and its metabolites. Sci Rep . 2022;12:3612.
96. Li VL, He Y, Contrepois K, et al. An exercise-inducible metabolite that suppresses feeding and obesity. Nature . 2022;606:785-790.
97. Lynn MA, Eden G, Ryan FJ, et al. The composition of the gut microbiota following early-life antibiotic exposure affects host health and longevity in later life. Cell Rep . 2021;36:109564.
98. Cabreiro F, Au C, Leung KY, et al. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism.Cell . 2013;153:228-239.
99. Pryor R, Norvaisas P, Marinos G, et al. Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy. Cell . 2019;178:1299-1312.e29.
100. Thomas RL, Jiang L, Adams JS, et al. Vitamin D metabolites and the gut microbiome in older men. Nat Commun . 2020;11:5997.
101. Gould AL, Zhang V, Lamberti L, et al. Microbiome interactions shape host fitness. Proc Natl Acad Sci U S A . 2018;115:E11951- E11960.
102. Agirman G, Yu KB, Hsiao EY. Signaling inflammation across the gut-brain axis. Science . 2021;374:1087-1092.
103. Kim B, Kanai MI, Oh Y, et al. Response of the microbiome-gut-brain axis in Drosophila to amino acid deficit. Nature . 2021;593:570-574.
104. Liu X, Li X, Xia B, et al. High-fiber diet mitigates maternal obesity-induced cognitive and social dysfunction in the offspring via gut-brain axis. Cell Metab . 2021;33:923-938.e6.
105. Yap CX, Henders AK, Alvares GA, et al. Autism-related dietary preferences mediate autism-gut microbiome associations. Cell . 2021;184:5916-5931.e17.
106. Wu WL, Adame MD, Liou CW, et al. Microbiota regulate social behaviour via stress response neurons in the brain. Nature . 2021;595:409-414.
107. Zhu S, Xu K, Jiang Y, et al. The gut microbiome in subclinical atherosclerosis: a population-based multiphenotype analysis.Rheumatology (Oxford) . 2021;61:258-269.
108. Beale AL, O’Donnell JA, Nakai ME, et al. The Gut Microbiome of Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc . 2021;10:e020654.
109. Israr MZ, Bernieh D, Salzano A, et al. Association of gut-related metabolites with outcome in acute heart failure. Am Heart J . 2021;234:71-80.
110. Brunt VE, Gioscia-Ryan RA, Richey JJ, et al. Suppression of the gut microbiome ameliorates age-related arterial dysfunction and oxidative stress in mice. J Physiol . 2019;597:2361-2378.
111. Gacesa R, Kurilshikov A, Vich Vila A, et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature . 2022;604:732-739.
112. Lehtisalo J, Rusanen M, Solomon A, et al. Effect of a multi-domain lifestyle intervention on cardiovascular risk in older people: the FINGER trial. Eur Heart J . 2022;43:2054-2061.
113. Walker RL, Vlamakis H, Lee JWJ, et al. Population study of the gut microbiome: associations with diet, lifestyle, and cardiometabolic disease. Genome Med . 2021;13:188.
114. Gruber J, Kennedy BK. Microbiome and Longevity: Gut Microbes Send Signals to Host Mitochondria. Cell . 2017;169:1168-1169.
115. Kundu P, Lee HU, Garcia-Perez I, et al. Neurogenesis and prolongevity signaling in young germ-free mice transplanted with the gut microbiota of old mice. Sci Transl Med . 2019;11:eaau4760.
116. Bárcena C, Valdés-Mas R, Mayoral P, et al. Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice.Nat Med . 2019;25:1234-1242.
117. Lurbe E, Ingelfinger J. Developmental and Early Life Origins of Cardiometabolic Risk Factors: Novel Findings and Implications.Hypertension . 2021;77:308-318.
118. Laroia G, Horne BD, Esplin S, Ramaswamy VK. A unified health algorithm that teaches itself to improve health outcomes for every individual: How far into the future is it? Digit Health . 2022;8:20552076221074126.
119. Ng R, Sutradhar R, Kornas K, et al. Development and Validation of the Chronic Disease Population Risk Tool (CDPoRT) to Predict Incidence of Adult Chronic Disease. JAMA Netw Open . 2020;3:e204669.
120. Vanlandewijck M, He L, Mäe MA, et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature . 2018;554:475-480.
121. Litviňuková M, Talavera-López C, Maatz H, et al. Cells of the adult human heart. Nature . 2020;588:466-472.
122. Garcia FJ, Sun N, Lee H, et al. Single-cell dissection of the human brain vasculature. Nature . 2022;603:893-899.